Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02808949Phase 1Completed
Phase 1, open-label, single-arm trial of dapivirine in human immunodeficiency virus infection (HIV), sponsored by International Partnership for Microbicides. Primary endpoint: Pharmacokinetics at 14 days. Started Feb 2015; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02808949.